Pelvis Adaptive Radiotherapy (ART)
Recruiting now · Not applicable
Conditions studied: Pelvis Neoplasms
In brief
Pelvis Adaptive radiotherapy (ART) is a two phase study looking at using adaptive radiotherapy to help reduce toxicity for cancer patients having radiotherapy in the pelvic region. Adaptive radiotherapy is a new technology that provides the ability to account for daily changes in anatomy. Adaptive radiotherapy also provides a foundation for which radiotherapy margins might be safely reduced. Phase 1 of this study is looking to see if a radiation therapist centred adaptive workflow can be implemented. If phase 1 of this study is safe and feasible, the study will proceed to phase 2. Phase 2 of the study looks at using adaptive technology to reduce radiation treatment margins. The primary aim of this study is to see whether margin reduced treatment using adaptive radiotherapy can reduce side effects for patients with cancer in the pelvic area.
Key facts
- Study ID
- NCT06650033
- Run by
- Royal North Shore Hospital
- People needed
- 280
- Starts
- 2025-10-09
- Expected to finish
- 2031-11-30
- Last updated by the study team
- 2026-02-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18
- ECOG performance status 0-2
- Patients receiving curative or adjuvant pelvic radiation including:
- Prostate cancer where nodal treatment is required
- Prostate cancer post prostatectomy
- Bladder cancer
- Rectal cancer
- Anal cancer
- Adjuvant radiotherapy for gynaecological cancers
- Pelvic Lymph nodes only
- Ability to understand and the willingness to sign an informed consent
You may not qualify if…
- Hip prosthesis
- Patient separation from approximate radiation centre to skin edge > 24cm, measured on diagnostic scan
Where it is running
- Northern Sydney Local Health District — St Leonards, New South Wales, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.